Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6efd738eb26ec31890b9e53e345c622 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2015-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_342653766b74a491afb654a53b1f95d8 |
publicationDate |
2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015153757-A1 |
titleOfInvention |
Microrna dosing regimens |
abstract |
A method of treating a subject, for example for a subject with a solid tumor or hematologic malignancy, can include administering a therapeutic treatment cycle to the subject, the cycle including daily microRNA mimic administrations on the first 3-7 consecutive days of the cycle followed by no microRNA administration on the next 7-21 consecutive days of the cycle. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9506061-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9611478-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4035659-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9642872-B2 |
priorityDate |
2014-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |